{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:36:49Z","timestamp":1771591009587,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1004801"],"award-info":[{"award-number":["2022YFA1004801"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1004801"],"award-info":[{"award-number":["2022YFA1004801"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special fund for Taishan industrial leading talent project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03614-1","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T08:02:53Z","timestamp":1706515373000},"page":"253-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification and functional characterization of compound heterozygous CYP11B1 gene mutations"],"prefix":"10.1007","volume":"84","author":[{"given":"He","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-6498","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinguo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"1","key":"3614_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","volume":"55","author":"K Bulsari","year":"2017","unstructured":"K. Bulsari, H. Falhammar, Clinical perspectives in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Endocrine 55(1), 19\u201336 (2017). https:\/\/doi.org\/10.1007\/s12020-016-1189-x","journal-title":"Endocrine"},{"issue":"10","key":"3614_CR2","doi-asserted-by":"publisher","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","volume":"114","author":"A Khattab","year":"2017","unstructured":"A. Khattab, S. Haider, A. Kumar, S. Dhawan, D. Alam, R. Romero et al. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Proc. Natl Acad. Sci. USA 114(10), E1933\u2013E1940 (2017). https:\/\/doi.org\/10.1073\/pnas.1621082114","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3614_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsbmb.2014.10.011","volume":"151","author":"L Schiffer","year":"2015","unstructured":"L. Schiffer, S. Anderko, F. Hannemann, A. Eiden-Plach, R. Bernhardt, The CYP11B subfamily. J. Steroid Biochem. Mol. Biol. 151, 38\u201351 (2015). https:\/\/doi.org\/10.1016\/j.jsbmb.2014.10.011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"3614_CR4","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1210\/en.2005-0096","volume":"146","author":"WL Miller","year":"2005","unstructured":"W.L. Miller, Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146(6), 2544\u20132550 (2005). https:\/\/doi.org\/10.1210\/en.2005-0096","journal-title":"Endocrinology"},{"issue":"3","key":"3614_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ajmg.a.20108","volume":"122A","author":"YS Zhu","year":"2003","unstructured":"Y.S. Zhu, J.J. Cordero, S. Can, L.Q. Cai, X. You, C. Herrera et al. Mutations in CYP11B1 gene: phenotype-genotype correlations. Am. J. Med Genet A 122A(3), 193\u2013200 (2003). https:\/\/doi.org\/10.1002\/ajmg.a.20108","journal-title":"Am. J. Med Genet A"},{"key":"3614_CR6","doi-asserted-by":"publisher","first-page":"595164","DOI":"10.1155\/2015\/595164","volume":"2015","author":"MA Alqahtani","year":"2015","unstructured":"M.A. Alqahtani, A.A. Shati, M. Zou, A.M. Alsuheel, A.A. Alhayani, S.M. Al-Qahtani et al. A novel mutation in the CYP11B1 gene causes steroid 11beta-hydroxylase deficient congenital adrenal hyperplasia with reversible cardiomyopathy. Int. J. Endocrinol. 2015, 595164 (2015). https:\/\/doi.org\/10.1155\/2015\/595164","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"3614_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s42000-021-00322-1","volume":"21","author":"I Fylaktou","year":"2022","unstructured":"I. Fylaktou, P. Smyrnaki, A. Sertedaki, M. Dracopoulou, C. Kanaka-Gantenbein, Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants. Hormones (Athens) 21(1), 155\u2013161 (2022). https:\/\/doi.org\/10.1007\/s42000-021-00322-1","journal-title":"Hormones (Athens)"},{"issue":"3","key":"3614_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2008.01.002","volume":"19","author":"S Nimkarn","year":"2008","unstructured":"S. Nimkarn, M.I. New, Steroid 11beta-hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol. Metab. 19(3), 96\u201399 (2008). https:\/\/doi.org\/10.1016\/j.tem.2008.01.002","journal-title":"Trends Endocrinol. Metab."},{"key":"3614_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gene.2017.05.029","volume":"626","author":"C Gu","year":"2017","unstructured":"C. Gu, H. Tan, J. Yang, Y. Lu, Y. Ma, Congenital adrenal hyperplasia due to 11-hydroxylase deficiency-Compound heterozygous mutations of a prevalent and two novel CYP11B1 mutations. Gene 626, 89\u201394 (2017). https:\/\/doi.org\/10.1016\/j.gene.2017.05.029","journal-title":"Gene"},{"issue":"4","key":"3614_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0162-0134(01)00331-2","volume":"87","author":"NV Belkina","year":"2001","unstructured":"N.V. Belkina, M. Lisurek, A.S. Ivanov, R. Bernhardt, Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. J. Inorg. Biochem. 87(4), 197\u2013207 (2001). https:\/\/doi.org\/10.1016\/s0162-0134(01)00331-2","journal-title":"J. Inorg. Biochem."},{"key":"3614_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2018.04.001","volume":"181","author":"F Bas","year":"2018","unstructured":"F. Bas, G. Toksoy, B. Ergun-Longmire, Z.O. Uyguner, Z.Y. Abali, S. Poyrazoglu et al. Prevalence, clinical characteristics and long-term outcomes of classical 11 beta-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene. J. Steroid Biochem. Mol. Biol. 181, 88\u201397 (2018). https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"3614_CR12","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","volume":"90","author":"KM Curnow","year":"1993","unstructured":"K.M. Curnow, L. Slutsker, J. Vitek, T. Cole, P.W. Speiser, M.I. New et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc. Natl Acad. Sci. USA 90(10), 4552\u20134556 (1993). https:\/\/doi.org\/10.1073\/pnas.90.10.4552","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"Pt A","key":"3614_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2016.03.006","volume":"165","author":"N Kandemir","year":"2017","unstructured":"N. Kandemir, D.Y. Yilmaz, E.N. Gonc, A. Ozon, A. Alikasifoglu, A. Dursun et al. Novel and prevalent CYP11B1 gene mutations in Turkish patients with 11-beta hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 165(Pt A), 57\u201363 (2017). https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"3614_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.gene.2015.04.052","volume":"565","author":"TP Nguyen","year":"2015","unstructured":"T.P. Nguyen, T.H. Nguyen, D.N. Ngo, C.D. Vu, T.K. Nguyen, V.H. Nong et al. A novel homozygous mutation IVS6+5G>T in CYP11B1 gene in a Vietnamese patient with 11beta-hydroxylase deficiency. Gene 565(2), 291\u2013294 (2015). https:\/\/doi.org\/10.1016\/j.gene.2015.04.052","journal-title":"Gene"},{"issue":"6","key":"3614_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1507\/endocrj.ej13-0509","volume":"61","author":"K Matsubara","year":"2014","unstructured":"K. Matsubara, N. Kataoka, S. Ogita, S. Sano, T. Ogata, M. Fukami et al. Uniparental disomy of chromosome 8 leading to homozygosity of a CYP11B1 mutation in a patient with congenital adrenal hyperplasia: implication for a rare etiology of an autosomal recessive disorder. Endocr. J. 61(6), 629\u2013633 (2014). https:\/\/doi.org\/10.1507\/endocrj.ej13-0509","journal-title":"Endocr. J."},{"issue":"9","key":"3614_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.6040\/j.issn.1671-7554.0.2017.218","volume":"55","author":"H Liu","year":"2017","unstructured":"H. Liu, F. Liu, X. Hou, L. Chen, A study of 11\u03b2 hydroxylase defect induced by a novel CYP11B1 gene mutation in one family. J. Shandong Univ. (Health Sci.) 55(9), 85\u201389 (2017). https:\/\/doi.org\/10.6040\/j.issn.1671-7554.0.2017.218","journal-title":"J. Shandong Univ. (Health Sci.)"},{"key":"3614_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fgene.2019.00630","volume":"10","author":"Y Qian","year":"2019","unstructured":"Y. Qian, J. Liu, Y. Yang, M. Chen, C. Jin, P. Chen et al. Paternal low-level mosaicism-caused SATB2-associated syndrome. Front. Genet 10, 630 (2019). https:\/\/doi.org\/10.3389\/fgene.2019.00630","journal-title":"Front. Genet"},{"issue":"4","key":"3614_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4), 402\u2013408 (2001). https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"4","key":"3614_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000342871","volume":"78","author":"C Xu","year":"2012","unstructured":"C. Xu, J. Qiao, W. Liu, X. Jiang, F. Yan, J. Wu et al. Identification and functional characterization of a large deletion of the CYP11B1 gene causing an 11beta-hydroxylase deficiency in a Chinese pedigree. Horm. Res. Paediatr. 78(4), 212\u2013217 (2012). https:\/\/doi.org\/10.1159\/000342871","journal-title":"Horm. Res. Paediatr."},{"key":"3614_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fped.2020.00410","volume":"8","author":"Q Zhou","year":"2020","unstructured":"Q. Zhou, D. Wang, C. Wang, B. Zheng, Q. Liu, Z. Zhu et al. Clinical and molecular analysis of four patients with 11beta-hydroxylase deficiency. Front. Pediatr. 8, 410 (2020). https:\/\/doi.org\/10.3389\/fped.2020.00410","journal-title":"Front. Pediatr."},{"key":"3614_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.steroids.2015.04.003","volume":"100","author":"X Wang","year":"2015","unstructured":"X. Wang, M. Nie, L. Lu, A. Tong, S. Chen, Z. Lu, Identification of seven novel CYP11B1 gene mutations in Chinese patients with 11beta-hydroxylase deficiency. Steroids 100, 11\u201316 (2015). https:\/\/doi.org\/10.1016\/j.steroids.2015.04.003","journal-title":"Steroids"},{"issue":"Pt A","key":"3614_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jsbmb.2015.10.011","volume":"155","author":"HH Nguyen","year":"2016","unstructured":"H.H. Nguyen, A. Eiden-Plach, F. Hannemann, E.M. Malunowicz, M.F. Hartmann, S.A. Wudy et al. Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene. J. Steroid Biochem. Mol. Biol. 155(Pt A), 126\u2013134 (2016). https:\/\/doi.org\/10.1016\/j.jsbmb.2015.10.011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"3614_CR23","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1210\/jcem.86.7.7671","volume":"86","author":"S Portrat","year":"2001","unstructured":"S. Portrat, P. Mulatero, K.M. Curnow, J.L. Chaussain, Y. Morel, L. Pascoe, Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86(7), 3197\u20133201 (2001). https:\/\/doi.org\/10.1210\/jcem.86.7.7671","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3614_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1297\/cpe.27.113","volume":"27","author":"K Matsubara","year":"2018","unstructured":"K. Matsubara, M. Kagami, M. Fukami, Uniparental disomy as a cause of pediatric endocrine disorders. Clin. Pediatr. Endocrinol. 27(3), 113\u2013121 (2018). https:\/\/doi.org\/10.1297\/cpe.27.113","journal-title":"Clin. Pediatr. Endocrinol."},{"issue":"3","key":"3614_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/jmedgenet-2013-101821","volume":"51","author":"EA Price","year":"2014","unstructured":"E.A. Price, K. Price, K. Kolkiewicz, S. Hack, M.A. Reddy, J.L. Hungerford et al. Spectrum of RB1 mutations identified in 403 retinoblastoma patients. J. Med. Genet 51(3), 208\u2013214 (2014). https:\/\/doi.org\/10.1136\/jmedgenet-2013-101821","journal-title":"J. Med. Genet"},{"issue":"8","key":"3614_CR26","doi-asserted-by":"publisher","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","volume":"99","author":"T Sahakitrungruang","year":"2014","unstructured":"T. Sahakitrungruang, C. Srichomthong, S. Pornkunwilai, J. Amornfa, S. Shuangshoti, S. Kulawonganunchai et al. Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 99(8), E1487\u2013E1492 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"3614_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"S. Baumgartner-Parzer, M. Witsch-Baumgartner, W. Hoeppner, EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur. J. Hum. Genet 28(10), 1341\u20131367 (2020). https:\/\/doi.org\/10.1038\/s41431-020-0653-5","journal-title":"Eur. J. Hum. Genet"},{"issue":"8","key":"3614_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tips.2016.05.006","volume":"37","author":"FP Guengerich","year":"2016","unstructured":"F.P. Guengerich, M.R. Waterman, M. Egli, Recent structural insights into cytochrome P450 function. Trends Pharm. Sci. 37(8), 625\u2013640 (2016). https:\/\/doi.org\/10.1016\/j.tips.2016.05.006","journal-title":"Trends Pharm. Sci."},{"issue":"10","key":"3614_CR29","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.drudis.2021.06.006","volume":"26","author":"D Machalz","year":"2021","unstructured":"D. Machalz, S. Pach, M. Bermudez, M. Bureik, G. Wolber, Structural insights into understudied human cytochrome P450 enzymes. Drug Discov. Today 26(10), 2456\u20132464 (2021). https:\/\/doi.org\/10.1016\/j.drudis.2021.06.006","journal-title":"Drug Discov. Today"},{"issue":"3","key":"3614_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1507\/endocrj.EJ15-0433","volume":"63","author":"Y Long","year":"2016","unstructured":"Y. Long, S. Han, X. Zhang, X. Zhang, T. Chen, Y. Gao et al. The combination of a novel 2 bp deletion mutation and p.D63H in CYP11B1 cause congenital adrenal hyperplasia due to steroid 11beta-hydroxylase deficiency. Endocr. J. 63(3), 301\u2013310 (2016). https:\/\/doi.org\/10.1507\/endocrj.EJ15-0433","journal-title":"Endocr. J."},{"key":"3614_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsbmb.2012.08.011","volume":"133","author":"M Zhang","year":"2013","unstructured":"M. Zhang, Y. Liu, S. Sun, H. Zhang, W. Wang, G. Ning et al. A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 133, 25\u201329 (2013). https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"3614_CR32","doi-asserted-by":"publisher","first-page":"185974","DOI":"10.1155\/2014\/185974","volume":"2014","author":"K Dumic","year":"2014","unstructured":"K. Dumic, T. Yuen, Z. Grubic, V. Kusec, I. Barisic, M.I. New, Two novel CYP11B1 gene mutations in patients from two croatian families with 11 beta-hydroxylase deficiency. Int J. Endocrinol. 2014, 185974 (2014). https:\/\/doi.org\/10.1155\/2014\/185974","journal-title":"Int J. Endocrinol."},{"issue":"8","key":"3614_CR33","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1210\/jcem.81.8.8768848","volume":"81","author":"S Geley","year":"1996","unstructured":"S. Geley, K. Kapelari, K. Johrer, M. Peter, J. Glatzl, H. Vierhapper et al. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81(8), 2896\u20132901 (1996). https:\/\/doi.org\/10.1210\/jcem.81.8.8768848","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3614_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0295-6","volume":"18","author":"X Yuan","year":"2018","unstructured":"X. Yuan, L. Lu, S. Chen, J. Jiang, X. Wang, Z. Liu et al. A Chinese patient with 11beta-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report. BMC Endocr. Disord. 18(1), 68 (2018). https:\/\/doi.org\/10.1186\/s12902-018-0295-6","journal-title":"BMC Endocr. Disord."},{"issue":"17","key":"3614_CR35","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1021\/acs.biochem.7b00034","volume":"56","author":"HM Peng","year":"2017","unstructured":"H.M. Peng, R.J. Auchus, Molecular recognition in mitochondrial cytochromes P450 that catalyze the terminal steps of corticosteroid biosynthesis. Biochemistry 56(17), 2282\u20132293 (2017). https:\/\/doi.org\/10.1021\/acs.biochem.7b00034","journal-title":"Biochemistry"},{"key":"3614_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.metabol.2017.03.003","volume":"71","author":"P Concolino","year":"2017","unstructured":"P. Concolino, R. Rizza, A. Costella, C. Carrozza, C. Zuppi, E. Capoluongo, CYP21A2 intronic variants causing 21-hydroxylase deficiency. Metabolism 71, 46\u201351 (2017). https:\/\/doi.org\/10.1016\/j.metabol.2017.03.003","journal-title":"Metabolism"},{"issue":"4","key":"3614_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/cen.14376","volume":"94","author":"MP Karlekar","year":"2021","unstructured":"M.P. Karlekar, V. Sarathi, A. Lila, K. Rai, S. Arya, V.V. Bhandare et al. Expanding genetic spectrum and discriminatory role of steroid profiling by LC-MS\/MS in 11beta-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 94(4), 533\u2013543 (2021). https:\/\/doi.org\/10.1111\/cen.14376","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"3614_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1515\/jpem-2020-0058","volume":"33","author":"W Dai","year":"2020","unstructured":"W. Dai, X. Zhang, H. Liu, Y. Sun, Y. Fan, Y. Yu, Two intronic variants of CYP11B1 and CYP17A1 disrupt mRNA splicing and cause congenital adrenal hyperplasia (CAH). J. Pediatr. Endocrinol. Metab. 33(9), 1225\u20131229 (2020). https:\/\/doi.org\/10.1515\/jpem-2020-0058","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"8","key":"3614_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/jmedgenet-2019-106145","volume":"57","author":"M Bao","year":"2020","unstructured":"M. Bao, P. Li, Q. Li, H. Chen, Y. Zhong, S. Li et al. Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting. J. Med. Genet 57(8), 571\u2013580 (2020). https:\/\/doi.org\/10.1136\/jmedgenet-2019-106145","journal-title":"J. Med. Genet"},{"key":"3614_CR40","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.jsbmb.2021.105899","volume":"211","author":"W Wang","year":"2021","unstructured":"W. Wang, R. Han, Z. Yang, S. Zheng, H. Li, Z. Wan et al. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia. J. Steroid Biochem. Mol. Biol. 211, 105899 (2021). https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105899","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"3614_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2169\/internalmedicine.52.8032","volume":"52","author":"JH Kim","year":"2013","unstructured":"J.H. Kim, G. Park, S.Y. Kim, H.Y. Bae, Thyrotoxic periodic paralysis with Graves\u2019 disease leading to the discovery of a hidden nonclassic 11beta hydroxylase deficiency. Intern. Med. 52(1), 85\u201388 (2013). https:\/\/doi.org\/10.2169\/internalmedicine.52.8032","journal-title":"Intern. Med."},{"issue":"9","key":"3614_CR42","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1210\/jcem.86.9.7820","volume":"86","author":"M Hampf","year":"2001","unstructured":"M. Hampf, N.T. Dao, N.T. Hoan, R. Bernhardt, Unequal crossing-over between aldosterone synthase and 11beta-hydroxylase genes causes congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86(9), 4445\u20134452 (2001). https:\/\/doi.org\/10.1210\/jcem.86.9.7820","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3614_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12020-018-1691-4","volume":"62","author":"LP Valadares","year":"2018","unstructured":"L.P. Valadares, A.C.V. Pfeilsticker, S.M. de Brito Sousa, S.C. Cardoso, O.L. de Moraes, L.C. Goncalves de Castro et al. Insights on the phenotypic heterogenity of 11beta-hydroxylase deficiency: clinical and genetic studies in two novel families. Endocrine 62(2), 326\u2013332 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1691-4","journal-title":"Endocrine"},{"issue":"9","key":"3614_CR44","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1210\/jc.2008-2521","volume":"94","author":"FC Soardi","year":"2009","unstructured":"F.C. Soardi, J.Y. Penachioni, G.Z. Justo, T.A. Bachega, M. Inacio, B.B. Mendonca et al. Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients. J. Clin. Endocrinol. Metab. 94(9), 3481\u20133485 (2009). https:\/\/doi.org\/10.1210\/jc.2008-2521","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3614_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000337974","volume":"77","author":"N Janzen","year":"2012","unstructured":"N. Janzen, F.G. Riepe, M. Peter, S. Sander, U. Steuerwald, E. Korsch et al. Neonatal screening: identification of children with 11beta-hydroxylase deficiency by second-tier testing. Horm. Res. Paediatr. 77(3), 195\u2013199 (2012). https:\/\/doi.org\/10.1159\/000337974","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"3614_CR46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2265.2007.02766.x","volume":"66","author":"M Andrew","year":"2007","unstructured":"M. Andrew, M. Barr, E. Davies, A.M. Wallace, J.M. Connell, S.F. Ahmed, Congenital adrenal hyperplasia in a Nigerian child with a novel compound heterozygote mutation in CYP11B1. Clin. Endocrinol. (Oxf.) 66(4), 602\u2013603 (2007). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02766.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"3614_CR47","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1210\/jcem.81.6.8964882","volume":"81","author":"CA Skinner","year":"1996","unstructured":"C.A. Skinner, G. Rumsby, J.W. Honour, Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene. J. Clin. Endocrinol. Metab. 81(6), 2389\u20132393 (1996). https:\/\/doi.org\/10.1210\/jcem.81.6.8964882","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3614_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3109\/07435800009048602","volume":"26","author":"O Chabre","year":"2000","unstructured":"O. Chabre, S. Portrat-Doyen, J. Vivier, Y. Morel, G. Defaye, Two novel mutations in splice donor sites of CYP11B1 in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Endocr. Res. 26(4), 797\u2013801 (2000). https:\/\/doi.org\/10.3109\/07435800009048602","journal-title":"Endocr. Res."},{"issue":"10","key":"3614_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1515\/jpem.2006.19.10.1267","volume":"19","author":"A Bhangoo","year":"2006","unstructured":"A. Bhangoo, R. Wilson, M.I. New, S. Ten, Donor splice mutation in the 11beta-hydroxylase (CypllB1) gene resulting in sex reversal: a case report and review of the literature. J. Pediatr. Endocrinol. Metab. 19(10), 1267\u20131282 (2006). https:\/\/doi.org\/10.1515\/jpem.2006.19.10.1267","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"3614_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/jcem.83.1.4513","volume":"83","author":"DP Merke","year":"1998","unstructured":"D.P. Merke, T. Tajima, A. Chhabra, K. Barnes, E. Mancilla, J. Baron et al. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 83(1), 270\u2013273 (1998). https:\/\/doi.org\/10.1210\/jcem.83.1.4513","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3614_CR51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000281417","volume":"74","author":"L Chabraoui","year":"2010","unstructured":"L. Chabraoui, F. Abid, R. Menassa, A. Gaouzi, A. El Hessni, Y. Morel, Three novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11Beta-hydroxylase deficiency in a Moroccan population. Horm. Res. Paediatr. 74(3), 182\u2013189 (2010). https:\/\/doi.org\/10.1159\/000281417","journal-title":"Horm. Res. Paediatr."},{"issue":"3","key":"3614_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000492496","volume":"90","author":"C Guzzetti","year":"2018","unstructured":"C. Guzzetti, C. Bizzarri, E. Pisaneschi, M. Mucciolo, E. Bellacchio, A. Ibba et al. Next-generation sequencing identifies different genetic defects in 2 patients with primary adrenal insufficiency and gonadotropin-independent precocious puberty. Horm. Res. Paediatr. 90(3), 203\u2013211 (2018). https:\/\/doi.org\/10.1159\/000492496","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"3614_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-016-0118-6","volume":"16","author":"P Charnwichai","year":"2016","unstructured":"P. Charnwichai, P. Yeetong, K. Suphapeetiporn, V. Supornsilchai, T. Sahakitrungruang, V. Shotelersuk, Splicing analysis of CYP11B1 mutation in a family affected with 11beta-hydroxylase deficiency: case report. BMC Endocr. Disord. 16(1), 37 (2016). https:\/\/doi.org\/10.1186\/s12902-016-0118-6","journal-title":"BMC Endocr. Disord."},{"issue":"7","key":"3614_CR54","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00431-009-1110-1","volume":"169","author":"K Dumic","year":"2010","unstructured":"K. Dumic, R. Wilson, P. Thanasawat, Z. Grubic, V. Kusec, K. Stingl et al. Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS+4A to G) in one CYP11B1 allele and R448H in exon 8 in the other. Eur. J. Pediatr. 169(7), 891\u2013894 (2010). https:\/\/doi.org\/10.1007\/s00431-009-1110-1","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"3614_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/jpem-2018-0298","volume":"32","author":"T Breil","year":"2019","unstructured":"T. Breil, V. Yakovenko, I. Inta, D. Choukair, D. Klose, J. Mittnacht et al. Typical characteristics of children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency: a single-centre experience and review of the literature. J. Pediatr. Endocrinol. Metab. 32(3), 259\u2013267 (2019). https:\/\/doi.org\/10.1515\/jpem-2018-0298","journal-title":"J. Pediatr. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03614-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03614-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03614-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:10:15Z","timestamp":1712110215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03614-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3614"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03614-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in line with the Declaration of Helsinki and was approved by the Ethics Committee of Shandong First Medical University (Approval No. R202210190129).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all the participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}